HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $256 | -25.6% | 6,695 | +10.8% | 1.28% | +6.3% |
Q4 2022 | $344 | -99.8% | 6,042 | +14.9% | 1.20% | +51.9% |
Q3 2022 | $208,000 | -31.4% | 5,257 | -23.6% | 0.79% | -11.0% |
Q2 2022 | $303,000 | +21.2% | 6,877 | +9.7% | 0.89% | +55.1% |
Q1 2022 | $250,000 | -8.1% | 6,267 | -7.3% | 0.57% | +32.0% |
Q4 2021 | $272,000 | -27.7% | 6,761 | -26.9% | 0.44% | -4.4% |
Q3 2021 | $376,000 | -11.5% | 9,254 | -1.0% | 0.46% | -8.6% |
Q2 2021 | $425,000 | -1.6% | 9,350 | -9.7% | 0.50% | +4.6% |
Q1 2021 | $432,000 | +104.7% | 10,359 | -23.3% | 0.48% | +106.1% |
Q3 2019 | $211,000 | – | 13,500 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |